In addition, stronger phosphorylation of AKT, GSK-3β, mTOR and its downstream effectors was found in CD157-high versus CD157-low AML cell lines exposed to FCS (as source of ECM proteins) or to purified ECM proteins that bind CD15717. The gene discussed is GSK3B; the disease is acute myeloid leukemia.